Powering Precision Medicine Through Genomic Intelligence
Transforming Patient Care with Advanced Genome Analytics
At Galaxi Genomics, we bridge the gap between complex genomic data and actionable clinical decisions. As a trusted partner to physicians worldwide, we specialize in interpreting patient genomes to deliver personalized treatment recommendations—helping doctors make evidence-based choices in oncology, neonatal care, and reproductive health.
Why Physicians Trust Our Genome Analysis Services?
Unparalleled Expertise at the Intersection of Genomics & Clinical Practice
From sample to report, we handle every step with precision:
Sequencing & QC – High-fidelity data generation using industry-leading platforms
Advanced Bioinformatics – AI-powered variant calling, annotation, and prioritization
Clinical Correlation – Interpretation by our physician-geneticist team, linking mutations to FDA-approved therapies, diagnostic and prognostic markers
Actionable Reporting – Clear, concise, and clinically structured for seamless integration into practice
End-to-End Genomic Interpretation with Clinical Context
We bring together:
Veteran oncologists and physicians who understand the nuances of patient care
Genomic data scientists with deep expertise in bioinformatics and AI-driven analysis
More than two decades of experience serving global pharmaceutical and biotech leaders, ensuring pharma-grade accuracy in our reports. Unlike generic genetic testing labs, we combine medical, computational, and therapeutic expertise to provide clinically relevant insights — not just raw data.
Specialized Focus Areas Where Genomics Makes the Biggest Impact
We deliver precision insights in three critical domains:
Oncology
Tumor-Normal Sequencing – Distinguishing somatic vs. germline mutations
Therapeutic Biomarkers – Matching variants to targeted therapies (e.g., BRCA, EGFR)
MSI testing – Relevant in identifying Lynch syndrome and predicting response to certain immunotherapies
Tumor Mutation Load assay – Used in cancer to predict a patient’s likelihood of responding to immunotherapy
HRD testing – Helps determine if a patient’s cancer is likely to respond to targeted therapies like PARP inhibitors
Neonatal & Rare Diseases
Whole-Genome and Exome Analysis – Diagnosing undetected genetic disorders
Carrier Screening – Assessing inherited risk for reproductive planning
Pharmacogenomics – Optimizing drug selection for pediatric patients
Reproductive Health
Non-Invasive Prenatal Testing (NIPT) – Early detection of fetal anomalies
Recurrent Pregnancy Loss Analysis – Identifying underlying genetic causes
Our Commitment to Advancing Precision Medicine
We don’t just process data—we translate it into better patient care by:
- Collaborating closely with physicians to refine reports based on real-world feedback
- Continuous knowledge updates incorporating the latest guidelines (AMP, ACMG, ESMO)
- Research partnerships with biopharma to stay ahead of emerging biomarkers